We are live on
!
Find out more
PIA
Philadelphia International Advisors Portfolio holdings
AUM
$239M
1-Year Est. Return
0.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.12%
1 Year Est. Return
+0.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$444M
AUM Growth
–
Cap. Flow
+$459M
Cap. Flow
% of AUM
103.31%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
78
New
78
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$32.8M |
| 2 |
Petrobras
PBR
|
+$22.7M |
| 3 |
Sabesp
SBS
|
+$13.6M |
| 4 |
CS
Credit Suisse Group
CS
|
+$13.1M |
| 5 |
POSCO
PKX
|
+$11.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.63% |
| 2 | Healthcare | 12.58% |
| 3 | Energy | 10.74% |
| 4 | Materials | 9.18% |
| 5 | Industrials | 5.6% |
Similar funds
VC
MRH
SIA
MWAN
PCM
UPA
AP
FSC
Philadelphia International Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Philadelphia International Advisors, which disclosed 78 positions worth $444M. Its ten largest holdings account for 31% of the portfolio.
Its largest position is Teva Pharmaceuticals: 842,396 shares worth $33M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, followed by Healthcare and Energy.
- Philadelphia International Advisors's largest Q2 2013 buy was Teva Pharmaceuticals: 842,396 shares worth $33M.
- Philadelphia International Advisors's ten largest holdings make up 31% of its $444M portfolio in Q2 2013.
- Philadelphia International Advisors disclosed 78 positions in Q2 2013, its first 13F filing on record.
Based on Philadelphia International Advisors's 13F filing for Q2 2013, filed 9 Aug 2013.